22157.jpg
Opioid Use Disorder Market Insights, Epidemiology and Forecasts, 2032: Treatment, Drug Class, Therapies, Outlook, Pipeline Activities, Treatment Programs
29 sept. 2023 10h13 HE | Research and Markets
Dublin, Sept. 29, 2023 (GLOBE NEWSWIRE) -- The "Opioid Use Disorder - Market Insight, Epidemiology and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The...
22157.jpg
Global Opioid Use Disorder Market Insights 2023-2032: Epidemiology, Drugs, Pipeline, Reimbursement, Competitors
23 juin 2023 04h08 HE | Research and Markets
Dublin, June 23, 2023 (GLOBE NEWSWIRE) -- The "Opioid Use Disorder - Market Insight, Epidemiology and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This...
BioCorRx Selects Covance for Non-Clinical Studies, Announces the Addition of Dr. Bal S. Brar to its Drug Development Team, Plans Pre-IND Meeting with FDA
28 nov. 2016 06h00 HE | BioCorRx
ANAHEIM, CA, Nov. 28, 2016 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTC PINK: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions,...
Assisted Recovery Centers of America Offers New Treatment Options for Alcohol Dependence
11 déc. 2006 15h28 HE | Assisted Recovery Centers of America
ST. LOUIS, Dec. 11, 2006 (PRIME NEWSWIRE) -- As a leader in the field, Assisted Recovery Centers of America (ARCA) continues to offer innovative treatment options as part of their comprehensive...